SiNtx Technologies Inc (SINT)

[Atlanta1]

$AMDA - I seriously doubt that this presentation is being scheduled to give disseminate bad news:

Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that it will host a conference call and live webcast to present the 24-month clinical results from a blinded, randomized clinical trial (CASCADE) that compared spinal fusion between its composite silicon nitride fusion devices with a central, cancellous ceramic core, to the industry standard of PEEK spacers filled with bone autograft.

Principal investigator Mark P. Arts, M.D., Ph.D., Neurosurgeon from the Medical Center Haaglanden, The Hague, Netherlands will present the data and Dr. Sonny Bal, Chairman and CEO of Amedica Corporation will discuss its impact on the business. Details related to this call are as follows:

Date: Monday March 7, 2016

Time: 2:00 p.m. Eastern Time

Conference ID: 55371714

Dial-in: Toll-free [phone]
International [phone]

Webcast: www.amedica.com